The Match Out: Resilience remains as stocks close marginally lower, Star (SGR) back on the boards

The daily Match Out for Wednesday 27 September 2023 with James Gerrish of Market Matters
James Gerrish

Market Matters

A solid session given the weak leads from the US overnight, inflation came in as expected while we saw some bargain hunting in the property sector with some interesting moves playing out after a tough time.

  • The ASX 200 finished down -7pts/ -0.11% to 7030 , up ~40pts from the days low.
  • The Property sector was best on ground (+0.44%) while Financials (+0.07%) also edged higher.
  • IT (-0.96%), Healthcare (-0.69%) and Energy (-0.42%) the weakest links, although there was some divergent stock performances across Healthcare.
  • Thanks to all who attended todays Webinar, looking for opportunities in unloved areas of the market – a timely one we think. A big attendance with a recording of the Webinar going to all subscribers + those who registered.
  • The attendance on Market Matters Webinars is growing monthly, and today we had more registrations than spaces available – for future webinars, please get in & register early!
  • Inflation data out today landed inline with expectations at 5.2% YoY, up from 4.9% driven largely by a rise in energy costs. While it was the first jump in 4 months, it was not a surprise.
  • Cash rate futures locally are now pricing in 20bps of tightening by Feb 24, before interest rate cuts are expected to kick in later in the year. The debate on whether on not the RBA will hike 1 more time is therefore a mute one, the market is already largely there, meaning an extended pause becomes a positive surprise.
  • ResMed (ASX: RMD) +4.79% bounced today, a couple of notes yesterday from Macquarie & Goldmans calling the rout overdone the likely catalyst. We agree, a huge amount of negativity priced into the stock, and while we think the heady days of a RMD multiple of 34x are done, on 19x it’s simply pricing in too much on the downside. Shorts have risen materially in RMD (particularly in the US) which could drive aggressive counter trend moves.
  • We covered our view of Eli Lilly (NYSE: LLY) this morning, the other side of the RMD coin, being a major beneficiary of weight loss treatments – read the note here
  • Star Entertainment (ASX: SGR) -8.42% back online post a $565m institutional placement at 60c with another $185m via a non-renounceable rights issue on a 1 for 1.65 basis. We cover SGR below. Stock closed today at 63.5c
  • Lots of media recently on ATI bank hybrids following an APRA paper discussing potential changes, our initial thoughts available here
  • Sigma Healthcare (ASX: SIG) -3.68% has a whiff to it, with price action implying some concern around their balance sheet.
  • Property stocks have had an awful time of late, but some interesting price action today, particularly Dexus (ASX: DXS) +2.79% which bounced hard from morning lows, while it’s not often we see Charter Hall Long WALE REIT (ASX: CLW) +2.13% in a session.
  • Bank of QLD (ASX: BOQ) -0.87% fell on a broker downgrade, Goldmans calling it a sell and $5.60 PT
  • We had Danny Younis on 3 years ago for a webinar (here) covering the future of retail. Lots of press on Danny this week as he offloads 2/3rds of his phenomenal wine collection at Auction. One of the largest wine collections ever to be auctioned in Australia, 5000 bottles with some fetching 30k (a bottle!) Interesting reading for the wine buffs – The Danny Younis Collection – the wines have aged better than a couple of the stock calls!
  • Iron Ore was marginally higher in Asia, up ~0.5%, Fortescue (ASX: FMG) +1.29% bounced.
  • Gold has been on the nose thanks to $US strength, the Dollar Index 106.25 pushing Gold back below US$1900/oz today. Gold stocks felt the heat, Northern Star (ASX: NST) -2.42% is starting to hurt!
  • Asian stocks were higher, Hong Kong up +0.74%, Japan up +0.19% while China added +0.38%
  • US Futures are higher, up around 0.25%.

ASX 200 chart - intraday 

ASX 200 chart - daily 

Star Entertainment (SGR) 63.5c

SGR -8.43%: the casino operator was back trading today after completing the bulk of a recapitalization raise that will vastly improve the balance sheet. Shareholders are able to buy 1 new share at 60c for every 1.65 held with the Institutional component of the entitlement offer raising $565m on 67% of rights taken up. The retail component will raise a further $185m, while Barclays and Westpac will offer a $450m debt facility to add flexibility to the balance sheet. The end result will see Star pay down all existing debt, clearing the slate as it looks to regain its earnings mojo. There are still concerns from an investment standpoint, an AUSTRAC fine hanging over the company’s head, as well as issues with Queens Wharf, their new Brisbane asset. However, the company said trading conditions have stabilized and the monthly revenue run rate was up 4% in July and August vs June quarter.

Broker moves 

  • Pro Medicus Cut to Market-Weight at Wilsons; PT A$81.20
  • Challenger Raised to Buy at Goldman; PT A$6.89
  • Pro Medicus Raised to Accumulate at CLSA; PT A$88.80
  • Bank of Queensland Cut to Sell at Goldman; PT A$5.60
  • Major movers today 

    Enjoy the night
    The Market Matters Team


    Make informed investment decisions

    At Market Matters, we write a straight-talking, concise, twice daily note about our experiences, the stocks we like, the stocks we don’t, the themes that you should be across and the risks as we see them. Click here for your free trial.

    The Match Out will be available each day after the market close. Follow my profile to be notified when the latest report is live.



    ........
    Livewire gives readers access to information and educational content provided by financial services professionals and companies ("Livewire Contributors"). Livewire does not operate under an Australian financial services licence and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any advice given. Any advice on this site is general in nature and does not take into consideration your objectives, financial situation or needs. Before making a decision please consider these and any relevant Product Disclosure Statement. Livewire has commercial relationships with some Livewire Contributors.

    1 topic

    James Gerrish
    Portfolio Manager
    Market Matters

    James is the Lead Portfolio Manager & primary author at Market Matters, a digital advice & investment platform with over 2500 members that offers real market intel & portfolios open for investment. He is also a Senior Portfolio Manager at Shaw and...

    I would like to

    Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

    Personal Information Collection Statement
    Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

    Comments

    Sign In or Join Free to comment